Cardiotoxicity and cardiovascular disease risk assessment for patients receiving breast cancer treatment.
Robyn A ClarkTania S MarinNarelle M BerryJohn J AthertonJonathon W FooteBogda KoczwaraPublished in: Cardio-oncology (London, England) (2017)
This study is an important step towards prevention and management of treatment-associated cardiotoxicity after breast cancer diagnosis. We recommend that our questionnaire is providing important data that should be included in cancer registries so that researchers can establish the relationship between CVD risk profile and cardiotoxicity outcomes and that this study revealed important teaching opportunities that could be used to examine the impact on health literacy and help patients better understand the consequences of cancer treatment.
Keyphrases
- cardiovascular disease
- risk assessment
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- type diabetes
- healthcare
- machine learning
- single cell
- coronary artery disease
- young adults
- cross sectional
- big data
- peritoneal dialysis
- patient reported outcomes
- health information
- human health
- artificial intelligence
- childhood cancer
- cardiovascular risk factors
- breast cancer risk